RaySearch Laboratories AB (publ)
STO:RAY B
Balance Sheet
Balance Sheet Decomposition
RaySearch Laboratories AB (publ)
Current Assets | 903.2m |
Cash & Short-Term Investments | 440.1m |
Receivables | 448.5m |
Other Current Assets | 14.5m |
Non-Current Assets | 1.2B |
PP&E | 583.4m |
Intangibles | 542.8m |
Other Non-Current Assets | 34.8m |
Current Liabilities | 745.9m |
Accounts Payable | 38.3m |
Other Current Liabilities | 707.6m |
Non-Current Liabilities | 541.8m |
Long-Term Debt | 430.2m |
Other Non-Current Liabilities | 111.6m |
Balance Sheet
RaySearch Laboratories AB (publ)
Dec-2014 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||
Cash & Cash Equivalents |
56
|
88
|
104
|
112
|
114
|
169
|
103
|
160
|
|
Cash |
0
|
88
|
104
|
112
|
0
|
0
|
0
|
0
|
|
Cash Equivalents |
56
|
0
|
0
|
0
|
114
|
169
|
103
|
160
|
|
Total Receivables |
0
|
334
|
419
|
459
|
423
|
362
|
384
|
398
|
|
Accounts Receivables |
0
|
330
|
414
|
431
|
386
|
301
|
0
|
371
|
|
Other Receivables |
0
|
4
|
5
|
28
|
37
|
61
|
0
|
28
|
|
Inventory |
0
|
0
|
0
|
10
|
5
|
9
|
30
|
14
|
|
Other Current Assets |
0
|
14
|
21
|
23
|
41
|
38
|
0
|
55
|
|
Total Current Assets |
0
|
436
|
544
|
604
|
582
|
577
|
516
|
628
|
|
PP&E Net |
0
|
36
|
36
|
93
|
221
|
187
|
667
|
649
|
|
PP&E Gross |
0
|
36
|
36
|
93
|
221
|
0
|
0
|
0
|
|
Accumulated Depreciation |
0
|
25
|
37
|
53
|
107
|
0
|
0
|
0
|
|
Intangible Assets |
0
|
243
|
323
|
377
|
428
|
487
|
523
|
519
|
|
Note Receivable |
0
|
2
|
12
|
23
|
20
|
27
|
10
|
55
|
|
Other Long-Term Assets |
0
|
1
|
1
|
7
|
12
|
7
|
29
|
26
|
|
Total Assets |
0
N/A
|
717
N/A
|
915
+28%
|
1 105
+21%
|
1 264
+14%
|
1 285
+2%
|
1 745
+36%
|
1 876
+8%
|
|
Liabilities | |||||||||
Accounts Payable |
0
|
12
|
27
|
32
|
33
|
20
|
49
|
24
|
|
Accrued Liabilities |
0
|
50
|
50
|
61
|
67
|
53
|
0
|
17
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
0
|
0
|
74
|
124
|
85
|
93
|
70
|
58
|
|
Other Current Liabilities |
0
|
63
|
81
|
119
|
173
|
263
|
398
|
515
|
|
Total Current Liabilities |
0
|
125
|
232
|
337
|
358
|
428
|
517
|
614
|
|
Long-Term Debt |
0
|
62
|
10
|
7
|
86
|
54
|
492
|
497
|
|
Deferred Income Tax |
0
|
71
|
92
|
104
|
115
|
109
|
108
|
107
|
|
Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
Total Liabilities |
0
N/A
|
257
N/A
|
335
+30%
|
448
+34%
|
559
+25%
|
591
+6%
|
1 116
+89%
|
1 219
+9%
|
|
Equity | |||||||||
Common Stock |
0
|
17
|
17
|
17
|
17
|
17
|
0
|
17
|
|
Retained Earnings |
0
|
449
|
567
|
646
|
694
|
685
|
0
|
640
|
|
Additional Paid In Capital |
0
|
2
|
2
|
2
|
2
|
2
|
0
|
2
|
|
Other Equity |
0
|
8
|
6
|
7
|
8
|
10
|
628
|
2
|
|
Total Equity |
0
N/A
|
460
N/A
|
580
+26%
|
657
+13%
|
705
+7%
|
694
-2%
|
628
-10%
|
657
+5%
|
|
Total Liabilities & Equity |
0
N/A
|
717
N/A
|
915
+28%
|
1 105
+21%
|
1 264
+14%
|
1 285
+2%
|
1 745
+36%
|
1 876
+8%
|
|
Shares Outstanding | |||||||||
Common Shares Outstanding |
0
|
34
|
34
|
34
|
34
|
34
|
34
|
34
|